









Markets
/
Stocks
/
nasdaq-ivp
/

Inspire Veterinary Partners Inc

IVP

0.820USD

+0.009+1.08%

Close 11/04, 16:00（ET）Quotes delayed by 15 min

4.38MMarket Cap

LossP/E TTM



Inspire Veterinary Partners Inc

0.820

+0.009+1.08%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Inspire Veterinary Partners Inc

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively weak. Its valuation is considered fairly valued,and institutional recognition is very high. The company shows very weak stock market performance, in line with its fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Inspire Veterinary Partners Inc's Score

Industry at a Glance

Industry Ranking

65 / 78

Overall Ranking

524 / 4616

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Inspire Veterinary Partners Inc Highlights

StrengthsRisks

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals throughout the United States. It specializes in small animal general practice hospitals which serve all manner of companion pets, emphasizing canine and feline breeds and including equine care. Services provided at its hospitals include preventive care for companion animals consisting of annual health exams, including parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; skin and coat health and many breed specific preventive care services. Surgical offerings include all soft tissue procedures, such as spays and neuters, mass removals, splenectomies and can also include gastropexies, orthopedic procedures and other types of surgical offerings based on a doctor’s training. In many locations, additional means of care and alternative procedures are also offered, such as acupuncture, chiropractic and various other health and wellness offerings.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 68.71% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 16.59M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 16.59M.

Fairly Valued

The company’s latest PE is -0.03, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 85.70K shares, decreasing 65.45% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 0.00 shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 5.41, which is lower than the Healthcare Providers & Services industry's average of 7.24. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 4.28M, representing a year-over-year decrease of 2.43%, while its net profit experienced a year-over-year decrease of 10.56%.

Score

Industry at a Glance

Previous score

5.41

Change



Financials

3.40

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.23

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

5.16

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

5.98

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

6.26

Key Metrics

Free cash flow

No Data

Inspire Veterinary Partners Inc's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 7.42, which is higher than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is -0.03, which is -140.53% below the recent high of 0.01 and -22930.90% above the recent low of -6.93.

Score

Industry at a Glance

Previous score

7.42

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 65/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

There is no earnings forecast score for this company; the Healthcare Providers & Services industry's average is 7.56.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

The company’s current price momentum score is 1.04, which is lower than the Healthcare Providers & Services industry's average of 7.02. Sideways: Currently, the stock price is trading between the resistance level at 0.97 and the support level at 0.71, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

1.04

Change

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.026

Sell

RSI(14)

33.245

Neutral

STOCH(KDJ)(9,3,3)

27.126

Neutral

ATR(14)

0.064

High Vlolatility

CCI(14)

-71.472

Neutral

Williams %R

73.558

Sell

TRIX(12,20)

-0.573

Sell

StochRSI(14)

66.356

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.823

Sell

MA10

0.857

Sell

MA20

0.907

Sell

MA50

0.933

Sell

MA100

1.000

Sell

MA200

1.440

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-04

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 2.35%, representing a quarter-over-quarter decrease of 78.15%. The largest institutional shareholder is The Vanguard, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Armistice Capital LLC

60.00K

-70.43%

UBS Financial Services, Inc.

12.15K

+1.67%

Geode Capital Management, L.L.C.

10.62K

+5.78%

Tower Research Capital LLC

2.72K

+25.58%

Osaic Holdings, Inc.

84.00

-47.50%

Harbour Investments, Inc

54.00

MAI Capital Management, LLC

39.00

BofA Global Research (US)

19.00

+72.73%

Wells Fargo Advisors

15.00

+275.00%

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 1.80, which is lower than the Healthcare Providers & Services industry's average of 5.44. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.